Activest Wealth Management’s Oncolytics Biotech ONCY Stock Holding History

Activest Wealth Management’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.75K	Hold	5,000	–	–	﹤0.01%	718
2026 Q1	$4.24K	Hold	5,000	–	–	﹤0.01%	845
2025 Q4	$4.37K	Hold	5,000	–	–	﹤0.01%	785
2025 Q3	$7K	Hold	5,000	–	–	﹤0.01%	580
2025 Q2	$3.87K	Hold	5,000	–	–	﹤0.01%	594
2025 Q1	$2.75K	Hold	5,000	–	–	﹤0.01%	603
2024 Q4	$4.57K	Hold	5,000	–	–	﹤0.01%	380
2024 Q3	$4.36K	Hold	5,000	–	–	﹤0.01%	374
2024 Q2	$4.95K	Buy	+5,000	New	+$5.45K	﹤0.01%	344

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

BPWM

Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Activest Wealth Management's ONCY Position: Q2 2026 in Review

Activest Wealth Management held its Oncolytics Biotech (ONCY) position steady in Q2 2026 at 5,000 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #718.

Activest Wealth Management first reported a position in ONCY in Q2 2024 and has held it in 9 quarters since. The position peaked at $7K in Q3 2025. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Activest Wealth Management held 5,000 shares of Oncolytics Biotech worth $4.75K as of Q2 2026.
Activest Wealth Management left its Oncolytics Biotech share count unchanged in Q2 2026.
Oncolytics Biotech made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #718 holding.
Activest Wealth Management first reported a position in Oncolytics Biotech in Q2 2024 and has held it in 9 quarters since.
Activest Wealth Management's Oncolytics Biotech position peaked at $7K in Q3 2025.
24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.